Literature DB >> 10648866

Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3' to 5' exonuclease activity.

Z Wang1, M Raifu, M Howard, L Smith, D Hansen, R Goldsby, D Ratner.   

Abstract

Degenerate primers were designed for PCR amplification of unknown mouse immunoglobulin (Ig) light (L) and heavy (H) chain variable (V) genes. Each subgroup of mouse Ig gene sequences [Kabat, E.A., Wu, T. T., Perry, H.H., Gottesman, K.S., Foeller, C., 1991. Sequences of Proteins of Immunological Interest, 5th edn. US Department of Health and Human Services, Public Health Service, NIH.] was analyzed, and highly degenerate primers in the framework one (FR1) region were designed. A single highly degenerate FR1 primer sufficed for the amplification of light chains; for heavy chains, a series of FR1 primers was used. At the same time, we assessed the effect of 3' to 5' exonuclease activity of DNA polymerase on the utilization of these degenerate primers. Using Taq polymerase, which lacks 3' to 5' exonuclease activity, we successfully amplified the Ig VL and VH genes expressed in more than a hundred monoclonal hybridoma cell lines reactive against a phosphonamidate hapten. Sequence analysis of the cloned VL and VH genes, 52 of each, showed that they are derived from multiple germline families (10 of the 17 VL families and 9 of the 14 VH families) as recently defined [Martinez, C., Lefranc, M., 1998. The mouse (Mus musculus) immunoglobulin kappa variable (IGKV) genes and joining (IGKJ) segments. Exp. Clin. Immunogenet. 15, 184.]. The universality of our primers was also demonstrated by successful amplification of other mouse hybridoma cell lines that are specific to different antigens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648866     DOI: 10.1016/s0022-1759(99)00184-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  78 in total

1.  A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.

Authors:  Hyunwook Lee; Sarah A Brendle; Stephanie M Bywaters; Jian Guan; Robert E Ashley; Joshua D Yoder; Alexander M Makhov; James F Conway; Neil D Christensen; Susan Hafenstein
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Design and Generation of Humanized Single-chain Fv Derived from Mouse Hybridoma for Potential Targeting Application.

Authors:  Kannika Khantasup; Warangkana Chantima; Chak Sangma; Kanokwan Poomputsa; Tararaj Dharakul
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-12

3.  Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.

Authors:  T Shibata; H Uchida; T Shiroyama; Y Okubo; T Suzuki; H Ikeda; M Yamaguchi; Y Miyagawa; T Fukuhara; J B Cohen; J C Glorioso; T Watabe; H Hamada; H Tahara
Journal:  Gene Ther       Date:  2016-02-23       Impact factor: 5.250

4.  Cloning murine antibody V-genes with non-degenerate primers and conversion to a recombinant antibody format.

Authors:  Magdalena Bialon; Ludmila Schellenberg; Nicolas Herzog; Stefan Kraus; Hannah Jörißen; Rainer Fischer; Christoph Stein; Jörg Nähring; Stefan Barth; Christiane Püttmann
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-12

5.  Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety.

Authors:  Fen Tang; Michelle E LeBlanc; Weiwen Wang; Dan Liang; Ping Chen; Tsung-Han Chou; Hong Tian; Wei Li
Journal:  Angiogenesis       Date:  2019-01-14       Impact factor: 9.596

6.  Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prions.

Authors:  Larry H Stanker; Miles C Scotcher; Alice Lin; Jeffery McGarvey; Stanley B Prusiner; Robert Hnasko
Journal:  Hybridoma (Larchmt)       Date:  2012-10

7.  The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies.

Authors:  Aparna Palakodeti; Andrew Sandstrom; Lakshmi Sundaresan; Christelle Harly; Steven Nedellec; Daniel Olive; Emmanuel Scotet; Marc Bonneville; Erin J Adams
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

8.  Engineered cell surface expression of membrane immunoglobulin as a means to identify monoclonal antibody-secreting hybridomas.

Authors:  Paul W Price; Elizabeth C McKinney; Youliang Wang; Loren E Sasser; Muthugapatti K Kandasamy; Linda Matsuuchi; Christine Milcarek; Roger B Deal; Deborah G Culver; Richard B Meagher
Journal:  J Immunol Methods       Date:  2009-01-31       Impact factor: 2.303

9.  Detection of botulinum neurotoxin serotype B at sub mouse LD(50) levels by a sandwich immunoassay and its application to toxin detection in milk.

Authors:  Miles C Scotcher; Luisa W Cheng; Larry H Stanker
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

10.  CD1d expression in paneth cells and rat exocrine pancreas revealed by novel monoclonal antibodies which differentially affect NKT cell activation.

Authors:  Elisa Monzon-Casanova; Birte Steiniger; Stefanie Schweigle; Holger Clemen; Daniela Zdzieblo; Lisa Starick; Ingrid Müller; Chyung-Ru Wang; Sara Rhost; Susanna Cardell; Elwira Pyz; Thomas Herrmann
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.